- (a) Specifications. Each milliliter of solution contains 5.0 milligrams atipamezole hydrochloride.
- (b) Sponsor. See Nos. 015914 and 052483 in § 510.600(c) of this chapter.
- (c) Conditions of use in dogs—(1) Amount. Inject intramuscularly the same volume as that of dexmedetomidine or medetomidine used.
- (2) Indications for use. For reversal of the sedative and analgesic effects of dexmedetomidine hydrochloride or medetomidine hydrochloride.
- (3) Limitations. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
[61 FR 48830, Sept. 17, 1996, as amended at 64 FR 71640, Dec. 22, 1999; 72 FR 264, Jan. 4, 2007; 84 FR 8973, Mar. 13, 2019]